Patrick Harrison Carroll Sells 23,726 Shares of Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS) insider Patrick Harrison Carroll sold 23,726 shares of the business’s stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $35.00, for a total transaction of $830,410.00. Following the completion of the sale, the insider directly owned 181,861 shares of the company’s stock, valued at approximately $6,365,135. This trade represents a 11.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health Trading Down 1.6%

Shares of NYSE:HIMS traded down $0.54 during trading on Tuesday, reaching $33.00. 12,512,469 shares of the company were exchanged, compared to its average volume of 30,262,973. The firm has a market capitalization of $7.64 billion, a PE ratio of -366.67, a P/E/G ratio of 50.70 and a beta of 2.37. The business’s fifty day simple moving average is $27.02 and its 200-day simple moving average is $26.54. Hims & Hers Health, Inc. has a 12-month low of $13.74 and a 12-month high of $70.43. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.69 and a quick ratio of 1.56.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.44). Hims & Hers Health had a negative net margin of 0.56% and a positive return on equity of 6.10%. The company had revenue of $608.10 million for the quarter, compared to the consensus estimate of $616.84 million. During the same period in the prior year, the firm posted $0.20 EPS. The business’s revenue was up 3.8% on a year-over-year basis. On average, research analysts anticipate that Hims & Hers Health, Inc. will post 0.05 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on HIMS shares. BTIG Research reissued a “neutral” rating on shares of Hims & Hers Health in a research report on Tuesday, May 12th. Jefferies Financial Group set a $24.50 price objective on shares of Hims & Hers Health in a research note on Tuesday, May 12th. Bank of America dropped their target price on shares of Hims & Hers Health from $28.00 to $25.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Truist Financial boosted their price target on shares of Hims & Hers Health from $18.00 to $23.00 and gave the company a “hold” rating in a report on Friday, May 22nd. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Hims & Hers Health from $35.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 12th. Four research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $29.37.

Hedge Funds Weigh In On Hims & Hers Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in HIMS. Western Wealth Management LLC bought a new position in Hims & Hers Health in the first quarter worth about $166,000. NewEdge Advisors LLC boosted its holdings in shares of Hims & Hers Health by 25.7% in the 1st quarter. NewEdge Advisors LLC now owns 38,173 shares of the company’s stock valued at $792,000 after buying an additional 7,800 shares in the last quarter. Avidity Partners Management LP purchased a new position in shares of Hims & Hers Health in the 1st quarter worth approximately $1,557,000. Bank of America Corp DE grew its position in shares of Hims & Hers Health by 194.4% in the 1st quarter. Bank of America Corp DE now owns 4,357,672 shares of the company’s stock worth $90,465,000 after buying an additional 2,877,550 shares during the last quarter. Finally, Sunbelt Securities Inc. grew its position in shares of Hims & Hers Health by 5,444.7% in the 1st quarter. Sunbelt Securities Inc. now owns 23,565 shares of the company’s stock worth $489,000 after buying an additional 23,140 shares during the last quarter. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc is a telehealth platform providing direct-to-consumer personal care products and virtual medical services in the United States. Operating under the Hims & Hers brand, the company offers an integrated digital experience that connects users with licensed healthcare providers, enabling online consultations and prescriptions for a range of conditions. Its telemedicine infrastructure supports both prescription medications and over-the-counter products, with home delivery to patients’ doorsteps.

The company’s product portfolio addresses key areas of men’s and women’s health, including hair loss treatments, sexual wellness therapies, skincare regimens and mental health support.